Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma.

PHASE3CompletedINTERVENTIONAL
Enrollment

466

Participants

Timeline

Start Date

June 13, 2017

Primary Completion Date

July 14, 2019

Study Completion Date

April 15, 2022

Conditions
Relapsed Multiple MyelomaRefractory Multiple Myeloma
Interventions
DRUG

Dexamethasone

Commercially available oral and IV formulas were obtained by investigative sites. Amgen supplied IV or PO dexa for some countries (Poland, Hungry, Romania, Bulgaria, Korea). Dosage modification rules applied based on participant age (participants \> 75 years were given lower doses), dexa-related toxicities, and discontinuation of carfilzomib.

DRUG

Daratumumab

Daratumumab was supplied as a concentrated solution for infusion in single-use vials.

DRUG

Carfilzomib

"Carfilzomib for infusion was supplied as a lyophilized, sterile product in single-use vials. The lyophilized product was reconstituted with preservative-free sterile water for injection, the reconstituted solution contained carfilzomib 2 mg/mL. IV injections lasted approximately 30 minutes.~Dose could be modified based on a \>20% change in body weight or toxicity."

Trial Locations (113)

1088

Semmelweis Egyetem, Budapest

1090

Universitair Ziekenhuis Brussel, Brussels

1097

Del-pesti Centrumkorhaz - Orszagos Hematologiai es Infektologiai Intezet, Budapest

1431

University Multiprofile Hospital for Active Treatment Sveti Ivan Rilski EAD, Sofia

1756

Specialized Hospital for Active Treatment of Hematology Diseases EAD, Sofia

2060

Ziekenhuis Netwerk Antwerpen Stuivenberg, Antwerp

2065

St Vincents Hospital Sydney, St Leonards

2145

Westmead Hospital, Westmead

2170

Liverpool Hospital, Liverpool

3000

Universitair Ziekenhuis Leuven - Campus Gasthuisberg, Leuven

3002

Epworth Healthcare, East Melbourne

3004

The Alfred Hospital, Melbourne

3065

St Vincents Hospital Melbourne, Fitzroy, VIC

3220

Barwon Health, University Hospital Geelong, Geelong

4002

University Multiprofile Hospital for Active Treatment Sveti Georgi EAD, Plovdiv

4029

Royal Brisbane and Womens Hospital, Herston

4032

Debreceni Egyetem Klinikai Kozpont, Debrecen

4102

Princess Alexandra Hospital, Woolloongabba

5000

Royal Adelaide Hospital, Adelaide

5020

Landeskrankenhaus Salzburg, Salzburg

5600

Bekes Megyei Kozponti Korhaz Dr Rethy Pal Tagkorhaz, Békéscsaba

6000

Grand Hôpital de Charleroi, Charleroi

6725

Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klinikai Kozpont Altalanos Orvostudomanyi Kar, Szeged

8036

Medizinische Universitaet Graz, Graz

9000

Universitair Ziekenhuis Gent, Ghent

10002

National Taiwan University Hospital, Taipei

10021

New York Presbyterian Hospital, Weill Cornell Medical College, New York

10408

National Cancer Center, Goyang-si, Gyeonggi-do

10676

General Hospital Evangelismos, Athens

11217

Taipei Veterans General Hospital, Taipei

11528

Alexandra Hospital, Athens

26504

General University Hospital of Patras Panagia i Voithia, Pátrai

28041

Hospital Universitario 12 de Octubre, Madrid

28204

Levine Cancer Institute, Charlotte

29414

Charleston Oncology, Charleston

30322

Emory University Winship Cancer Institute, Atlanta

31008

Clinica Universidad de Navarra, Pamplona

33486

Lynn Cancer Center Boca Raton Regional Hospital, Lynn Cancer Institute, Boca Raton

33604

Centre Hospitalier Universitaire de Bordeaux - Hopital Haut Leveque, Pessac

35040

Ege University Faculty of Medicine, Izmir

37007

Hospital Clinico Universitario de Salamanca, Salamanca

39401

Hattiesburg Clinic Hematology/Oncology, Hattiesburg

44093

Centre Hospitalier Universitaire de Nantes, Nantes

44622

Gabrail Cancer Center, LLC, Dover

46845

Fort Wayne Medical Oncology and Hematology, Fort Wayne

54007

Theagenion Cancer Hospital of Thessaloniki, Thessaloniki

54511

Centre Hospitalier Universitaire de Nancy - Hopital de Brabois, Vandœuvre-lès-Nancy

55139

Ondokuz Mayis Universitesi Tip Fakultesi, Samsun

58128

Chonnam National University Hwasun Hospital, Hwasun, Jeollanam-do

59037

Centre Hospitalier Régional Universitaire de Lille - Hôpital Claude Huriez, Lille

69495

Centre Hospitalier Lyon Sud, Pierre-Bénite

75246

Baylor Charles A Sammons Cancer Center at Dallas, Dallas

78157

Centre Hospitalier de Versailles - Hopital Andre Mignot, Le Chesnay

85925

Centre Hospitalier Départemental les Oudairies, La Roche-sur-Yon

86021

Centre Hospitalier Universitaire de Poitiers - Hopital la Miletrie, Poitiers

185019

SBHI of Republic of Karelia Republic Hosiptal n a V A Baranov, Petrozavodsk

200143

Spitalul Clinic Municipal Filantropia Craiova, Craiova

400124

Profesor Dr Ion Chiricuta Institut of Oncology, Cluj-Napoca

410028

Clinic of professional pathology and hematology, Saratov

443079

State Budget Educational Institution of High Professional Skills Samara State Medical University, Samara

500152

Policlinica de Diagnostic Rapid, Brasov

603126

SBHI of Nizhny Novgorod region Regional Clinical Hospital of Nizhny Novgorod na N A Semashko, Nizhny Novgorod

60637-6613

University of Chicago Medical Center - Multiple Myeloma Research Consortium, Chicago

07601

Hackensack University Medical Center, Hackensack

T2N 4N2

Tom Baker Cancer Centre, Calgary

T6G 1Z2

Cross Cancer Institute, Edmonton

K1H 8L6

Ottawa Hospital Research Institute, Ottawa

M5G 2M9

Princess Margaret Cancer Centre, Toronto

H1T 2M4

Hopital Maisonneuve-Rosemont, Montreal

625 00

Fakultni nemocnice Brno, Brno

500 05

Fakultni nemocnice Hradec Kralove, Hradec Králové

708 52

Fakultni nemocnice Ostrava, Ostrava-Poruba

304 60

Fakultni nemocnice Plzen, Pilsen

128 08

Vseobecna fakultni nemocnice v Praze, Prague

467-8602

Nagoya City University Hospital, Nagoya

441-8570

Toyohashi Municipal Hospital, Toyohashi

296-8602

Tesshokai Kameda General Hospital, Kamogawa-shi

811-1395

National Hospital Organization Kyushu Cancer Center, Fukuoka

812-8582

Kyushu University Hospital, Fukuoka

503-8502

Ogaki Municipal Hospital, Ogaki-shi

371-8511

Gunma University Hospital, Maebashi

377-0280

National Hospital Organization Shibukawa Medical Center, Shibukawa-shi

602-8566

University Hospital Kyoto Prefectural University of Medicine, Kyoto

951-8566

Niigata Cancer Center Hospital, Niigata

701-1192

National Hospital Organization Okayama Medical Center, Okayama

565-0871

Osaka University Hospital, Suita-shi

350-8550

Saitama Medical Center, Kawagoe-shi

320-0834

Tochigi Cancer Center, Utsunomiya

770-8539

Tokushima Prefectural Central Hospital, Tokushima

135-8550

Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku

150-8935

Japanese Red Cross Medical Center, Shibuya-ku

15-732

InterHem, Bialystok

41-500

Samodzielny Publiczny Zaklad Opieki Zdrowotnej Zespol Szpitali Miejskich w Chorzowie, Chorzów

20-090

Centrum Onkologii Ziemi Lubelskiej im Swietego Jana z Dukli, Lublin

60-569

Szpital Kliniczny Przemienienia Panskiego Uniwersytetu Medycznego im K Marcinkowskiego w Poznaniu, Poznan

02-776

Instytut Hematologii i Transfuzjologii, Warsaw

50-367

Uniwersytecki Szpital Kliniczny im Jana Mikulicza-Radeckiego we Wroclawiu, Wroclaw

020125

Spitalul Clinic Colentina, Bucharest

022328

Fundeni Clinical Institute, Bucharest

030171

Coltea Clinical Hospital, Bucharest

050098

Bucharest Emergency University Hospital, Bucharest

03080

Seoul National University Hospital, Seoul

03722

Severance Hospital Yonsei University Health System, Seoul

05505

Asan Medical Center, Seoul

06351

Samsung Medical Center, Seoul

06591

The Catholic University of Korea Seoul St Marys Hospital, Seoul

08916

Hospital Universitari Germans Trias i Pujol, Badalona

08036

Hospital Clinic i Provincial de Barcelona, Barcelona

06100

Hacettepe Universitesi Tip Fakultesi, Ankara

06590

Ankara Universitesi Tip Fakultesi Cebeci Hastanesi, Ankara

LS9 7TF

St James University Hospital, Leeds

NW1 2PG

University College London Hospital, London

M20 4BX

Christie Hospital, Manchester

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amgen

INDUSTRY

NCT03158688 - Study of Carfilzomib, Daratumumab and Dexamethasone for Patients With Relapsed and/or Refractory Multiple Myeloma. | Biotech Hunter | Biotech Hunter